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Striated muscle myosins are encoded by a large 
gene family in all mammals, including human. 
These isoforms define several of the key 
characteristics of the different striated muscle 
fiber types including maximum shortening 
velocity. We have previously used recombinant 
isoforms of the motor domains of seven 
different human myosin isoforms to define the 
actin.myosin cross-bridge cycle in solution. 
Here we present data on an eighth isoform the 
perinatal, which has not previously been 
charaterized. The perinatal is distinct from the 
embryonic isoforms appearing to have features 
in common with the adult fast muscle isoform, 
including weak affinity of ADP for A.M and 
fast ADP release. We go on to use a recently 
developed modeling approach MUSICO to 
explore how well the experimentally defined 
cross-bridge cycles for each isoform in solution 
can predict the characteristics of muscle fiber 
contraction including duty ratio, shortening 
velocity, ATP economy and the load 
dependence of these parameters. The work 
shows that the parameters of the cross-bridge 
cycle predict many of the major characteristics 
of each muscle fiber type and raises the 
question of what sequence changes are 
responsible for these characteristics.  
Introduction 
Muscle myosin in all mammals consists of a 
variety of isoforms, each expressed from its 
own gene (see Table 1 and references therein). 
There are 10 such genes in the human genome, 
and one pseudogene. All of the striated muscle 
Human muscle myosin isoforms 
2 
 
myosin sequences are very highly conserved, 
but each has functional differences and these 
differences are required for normal muscle 
function since myosin isoform-specific null 
mice can have profound phenotypes (1). 
Further, disease-causing mutations in 6 of the 
10 genes have been reported (2, 3). The 
expression of these genes is regulated 
temporally and spatially and can be affected by 
physical activity, animal species and hormonal 
status.  Each myosin isoform confers distinct 
contractile characteristics to each muscle fiber 
type (4, 5).  These characteristics include 
maximum shortening velocity, rate of ATP 
usage, the economy of ATP usage and the 
velocity at which power output is maximal.   
Other parameters such as maximal force per 
cross-bridge or step size are much less variable 
(4, 5).  How each myosin is tuned for its specific 
function is not well understood. Also poorly 
understood is how changes in the amino acid 
sequence of each myosin bring about the 
functional changes.  As a first step to 
understand how striated muscle myosin has 
evolved to have distinct physiological roles, we 
first needed to understand how the ATP driven 
cross-bridge cycle varies between the isoforms.  
Towards that end, we  recently published a 
complete characterization of the kinetics of the 
ATPase cycle for the motor domains of six, 
adult human muscle-myosin isoforms and the 
embryonic isoform ((6–8), see Table 1).  Here 
we extend this data set to include the first study 
of the human perinatal myosin isoform.  We 
show here that the perinatal isoform is quite 
distinct from the embryonic form and has more 
in common with adult fast muscle isoforms.  
With this large set of isoform data, it is possible 
to examine the extent to which differences in 
the ATPase cycle for each isoform can predict 
the differences in mechanochemical properties 
of muscle fibers expressing them. Here we use 
the recently developed MUSICO modeling 
approach  (9, 10) to predict the contraction 
characteristics of each muscle fiber type and 
compare the predictions to published data for 
single muscle fibers expressing single myosin 
isoforms. 
 
Using MUSICO we recently re-examined the 
actin myosin-S1 ATPase cycle of fast rabbit 
muscle using both fast kinetic methods and 
steady-state ATPase assays to establish the 
primary parameters of an 8-step actin-myosin 
cross-bridge cycle (Fig 1; (9)).  These 
parameters were then used with the addition of 
the overall ATPase parameters for the cycle, the 
kcat (or Vmax) and Kapp (concentration of actin 
needed for half maximum ATPase rates) to 
model the complete cycle in solution.  This 
allowed the occupancy of each state of the cycle 
to be predicted as a function of actin 
concentration. The occupancies calculated 
were then used to predict the duty ratio (DR; the 
proportion of the cycle myosin is bound to 
actin), the expected maximal velocity of 
contraction, (V0, in a motility assay or muscle 
sarcomere shortening) as a function of actin 
concentration and the effect of a 5 pN load on 
state-occupancies for a single motor.  To test 
this approach we compared the information 
obtained for rabbit fast muscle myosin with  
two human cardiac myosin isoforms (α and β) 
that we had characterized previously (6).  These 
illustrated how the cycle was altered to define 
myosins with different velocities and different 
sensitivities to load.  While the duty ratio was 
largely unchanged among isoforms, the 
ATPase cycling rates and predicted velocities 
were altered in line with published 
experimental data.  The effect of load reduced 
the predicted velocities and ATPase rates but to 
differing extents.  Here, we have added in 
predictions about the economy of ATP usage 
during rapid shortening and whilst holding a 5 
pN load. 
 
In the current study, the analysis described 
above has been extended to four additional 
adult, fast-skeletal, human isoforms (IIa, IIb, 
IId and extraocular; ExOc) together with two 
developmental isoforms: embryonic (Emb) and 
perinatal (Peri) myosins.  The analysis reveals 
that the relative velocities predicted for the 
isoforms vary widely (9-fold).  Duty ratios vary 
over a narrow 2 fold range while economy of 
ATP usage varies 4-5 fold. Experimental data 
for these values are only available for a limited 
number of isoforms, but where available are 
compatible with our predictions.  The extent to 
which these ATPase cycle studies can predict 
the properties of contracting muscle for both the 
well-defined and unstudied isoforms e.g. ExOc, 
Peri is discussed.  
 
 
Results & Discussion 
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We have modelled, using MUSICO, the 
complete ATPase cycle for all isoforms listed 
in Table 1.  The modeling used the previously 
published values for the rate and equilibrium 
constants (Table S1) that have defined the cycle 
shown in Fig 1.  The best fit parameters are 
listed in Table 2.  In all cases, the measured 
constants were defined with a precision of at 
least ± 20%.  The limitations of this precision 
on the modeling will be considered  below, but 
in general, varying any of the parameters by ± 
20% has a limited effect on the cycle; in most 
cases altering the occupancy of each state by 
much less than 20%.  One new set of 
experimental data is presented here, that for the 
Peri isoform.  Data collection was identical to 
that presented for all other isoforms, and the 
measured parameters are listed in Table S1.   
  
Using a combination of best fit and measured 
values for the cycle, the occupancy of each state 
in the cycle was calculated at three different 
actin concentrations [actin] = Kapp, (the actin 
concentration required for 50% of the Vmax of 
the ATPase) and [actin] = 3·Kapp and 20·Kapp 
(actin concentration required for 75% and 95% 
of Vmax respectively).  A range of actin 
concentrations was chosen because it is not 
known what the appropriate actin concentration 
is in muscle fibers. Fig 2 presents the calculated 
occupancies for each state in the cycle as pie 
charts for each isoform.  The color scheme of 
the pie charts matches that of the ATPase cycle 
states shown in Fig1, where red shades 
represent detached states, yellow shades 
weakly attached states and blue shades strongly 
attached states. 
  
α & β Cardiac isoforms 
 
 For β-cardiac myosin, at low actin 
concentrations ([actin] = Kapp,), the detached 
state M·D·Pi, predominated (pale red shade; 
~45-50%), with similar amounts of the 
detached M·T and the weakly attached A-
M·D·Pi state (each ~25%). Only 6.8 % of the 
myosin is strongly attached as A·M·D, the 
predominant force holding state.  All other 
species in the cycle have very low occupancy in 
the steady-state.  As actin concentration 
increased (to 3 Kapp; 75 % Vmax and 20Kapp; 95 
% Vmax) the total occupancy of the detached 
states fell to ~ 50% and then 25% and the 
weakly attached A-M·ATP and A-M·D·Pi 
increased from <25% to 35% and then >50% as 
expected. The strongly attached force holding 
states are dominated by the pale blue A·M·D 
state, which increases from 6.8% at low actin 
concentrations to 10% and 13.0 % as the actin 
concentration approached saturation.  Thus, the 
DR is dominated by A·M·D and lies between 
0.07 and 0.14, depending upon the actin 
concentration, at the zero load experienced in 
these solution assays.  A similar pattern was 
observed for the human α-myosin except a 
slightly higher level of the A·M·D state, 
between 9.0% and 17.6% depending upon the 
actin concentration and a DR of 0.1 to 0-0.19. 
 
Table 2 and Fig 2 list the measured kcat values 
(ATPase cycling rates) for the α- and β-
isoforms.  Despite quite similar occupancies of 
the intermediates in the cycle, the cycling rates 
are very different; α-cardiac turns over ATP 
almost three times faster than β-cardiac. The 
predicted velocities were 2.25 fold faster for the 
α- vs the β-isoform (Fig 3, Table 3) which is 
similar to measured values (11).  This 
calculation assumes an average 5 nm step for 
both. This result has implications for the 
economy of ATP usage which will be discussed 
below (see Fig 5).   
 
Single molecule laser trap assays have provided 
estimates of the load dependency of the ADP 
release rate constant (kD*) for human β myosin, 
and indicate that this rate constant slows down 
by ~ a factor of 3 for a load of 5 pN (see 
methods (12, 13)).  We argued that a similar 
load dependence is expected on the force 
generating step / Pi release step (kPi in Fig 1) 
and for the values used in the cycle a 3-fold 
reduction in kPi is required to slow the ATPase 
cycling rate under load, as has been reported for 
contracting muscle fibers (14, 15). Slowing 
both rate constants (kPi and kD*) down by a 
factor of 3 allows us to explore how the cycle 
would change under a 5 pN load, approaching 
the load which might be expected during 
isometric contraction of a fiber.  The results are 
illustrated in the last row of the pie charts in Fig 
2 for an actin concentration of 3Kapp and the 
predicted effect on the ATPase rates and 
velocity of shortening are illustrated in Fig 3.  
There is no measurement of the load 
dependence of ADP release for any isoform 
other than β cardiac.  For the purposes of 
illustration throughout we assume a similar 
load dependence for all isoforms to understand 
how a load may influence the cycle differently 
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based on the observed differences in the cycle 
rate constants.   The data for the effect of load 
on the state occupancy, the ATPase rate and the 
velocity is presented in Fig 2 & 3 and Table 3. 
For both α and β the ATPase cycling rates were 
reduced by approximately a factor of 3 while 
the occupancy of the A·M·D state increased 
from 10.2 to 13.6% for human β and 13.5 to 15 
.5% for α. This implies that for an ensemble of 
myosins (in a thick filament or sarcomere) the 
α-myosin would maintain a higher occupancy 
of the force holding states. Note however, for 
β-myosin the occupancy of A·M·D increases 
by 1/3rd under load, while for α-myosin, the 
occupancy increases by only ~1/7th.  
 
Embryonic isoform  
 
The complete experimental data set for the 
human Emb isoform was published in 2016 (8) 
and the published data are  reproduced in Table 
S1. The results of the modeling are presented in 
Fig 2 - 4 in the same format as for the α- and β-
isoforms for ease of comparison. 
 
What is immediately striking in the Emb data 
set is that although the kcat values for the Emb 
and β isoforms are similar (7.0 and 5.9 s-1 
respectively) there are marked differences in 
the occupancy of the force holding A·M·D state 
(pale blue; Fig 1).  While the detached M·D·Pi 
(pale red) and A-M·D·Pi (pale yellow) appear 
similar for β and Emb, the detached M·T (red) 
state is much smaller and the A·M·D state (pale 
blue) was much larger for Emb than for β (e.g. 
A·M·D = 26.5% for Emb vs 10.24% at [actin] 
= 3Kapp). This difference was less marked when 
compared to the α-isoform.  This large 
difference in A·M·D occupancy and duty ratio 
are brought about through differences in the 
contribution of three steps to the overall cycling 
speed (kcat): the hydrolysis step kH, the 
phosphate release step kPi, and ADP release step 
kD*. For β myosin, kH and kPi are comparable at 
2-3 fold kcat while kD* is 10-fold larger than kcat 
(see Table 4).  Thus, as seen in Fig 2 for the β 
isoform at high actin concentration ([actin] = 20 
Kapp), the predominant states are the ATP states 
M·T and A-M·T (together 45%), the weakly 
bound A-M·D·Pi (35%) and A·M·D (12.9%).  
In the case of Emb, kcat is similar to that of β but 
the balance of the cycle is quite different: kH is 
10 kcat and kPi and kD* are now comparable at 2-
3 fold kcat. So the ATP states M·T and A-M·T 
are much smaller than kD*, while the A-M·D·Pi 
(51%) and A·M·D (33%) states predominate, 
and thus a much larger DR is observed for Emb 
myosin. 
 
The higher occupancy of the force holding 
A·M·D state implies that the Emb isoform 
would be much better at holding loads than 
either of the two cardiac isoforms discussed so 
far. Assuming a similar load-holding capacity 
for each cross-bridge independent of the 
isoform, then there are almost twice as many 
cross-bridges present in the steady-state for 
Emb myosin, which suggests a fiber expressing 
Emb myosin would need to activate half the 
number of cross-bridges (per sarcomere or per 
thick filament) to hold the same load as a fiber 
expressing β myosin. At the whole fiber or 
whole muscle level, the differences in the 
packing of the filaments would need to be 
considered. 
 
In contrast to β or α, the presence of a 5 pN load 
on Emb has almost no effect on the occupancy 
of the force holding A·M·D state or the duty 
ratio.  This was unexpected, but a closer 
examination of the effect of load suggests that 
since kD* and kPi are both similar and dominate 
the ATPase cycling rate, when both are reduced 
to a similar extent by load, ATPase cycling is 
reduced by a factor of 3 but the balance of states 




Like Emb, Peri is found in developing and 
regenerating muscle (2, 16). No biochemical 
kinetic study of this isoform has been 
published.  Using the C2C12 expression system 
we have expressed the motor domain and 
completed a kinetic analysis as previously 
described for the other isoforms. Details of the 
measurements are given in Supplementary 
information (Fig S1-S4).  The measured values 
for the steps in the ATPase cycle are listed in 
Table S1. The data do show distinct differences 
compared to the both the cardiac and Emb 
isoforms discussed so far.  
  
As the Peri and Emb myosins are both 
developmental isoforms, a comparison between 
these is drawn here. A full comparison can be 
seen in Table S1. In the absence of actin, the 
Peri S1 had an almost 3-fold slower second 
order rate constant of ATP binding to S1 
compared to the Emb isoform (4.5 µM-1 s-1 vs 
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12.5 µM-1 s-1). The maximum rate of ATP 
binding (kH + k-H) is almost 50% slower for the 
Peri than for the Emb (68.7 s-1 vs 130 s-1). This 
is assumed to measure of the ATP hydrolysis 
step. The Peri actin.S1 had a maximum rate of 
dissociation (k+T*) of 856 s-1, and is similar to 
the Emb S1 (777 s-1). However, the ATP 
binding affinity (KT), and hence the second 
order rate constant (KTk+T*), was almost two 
fold tighter than that of Emb (146.5 vs 84.3 µM 
Peri and Emb respectively). The crucial 
difference between the two developmental 
isoforms is the ADP release rate (k+D*) which is 
considerably faster (>700 s-1) than the Emb 
isoform (22 s-1). A slow ADP release rate is 
indicative of a slow type isoform such as β and 
Emb whereas the Peri is more like the fast 
skeletal isoforms (α, IIa, IIb, IId, ExOc).  
However, as shown in Fig S2 the rate constant 
for ADP release (kD = 700 s-1) is only 
marginally slower than the maximum rate of 
actin dissociation by ATP (kT* = 856 s-1).  We 
have assigned this to kD*, but it could equally be 
assigned to kD.  
 
The ATPase of the Peri isoform is much faster 
than Emb with a kcat of almost 30 s-1 and the 
rapid release of ADP from A·M·D suggests a 
fast type myosin (17).   The results of the 
modeling are shown in Fig 2-4.    
 
Modeling the cycle shows a similar pattern to 
the α- and β-myosins but with some key 
differences.  The occupancy of the force 
holding, pale blue, A·M·D state (pale blue) is 
much smaller for Peri (~4.1% at [A] =20 Kapp) 
compared to α (17%) or β (13%) resulting in a 
smaller DR (0.11) than for β (0.14).  The 
difference in DR could be considered small but 
examination of the pie charts in Fig 2 show a 
redistribution amongst the strongly attached 
states with the presence of significant amounts 
of the strongly attached states, A·M-D (~2.8%) 
and A·M·T (~3.5%) in addition to A·M·D.  The 
presence of other strongly attached states 
appears to be a feature of the fast type myosins 
and will be discussed further when the fast adult 
myosins are considered. 
 
Similar to the result for Emb isoform, the 
change in occupancy observed here for Peri is 
the result of changes in the balance between kPi, 
kD* and kH and their contributions to kcat.   While 
the rate of the hydrolysis step, controlled by kH, 
is much faster for Peri at 68.7 s-1 than for β (13.9 
s-1), it is only twice the value of kcat. This means 
that the M·T and A-M·T states dominate at all 
actin concentrations considered, even more 
than is the case for β-myosin.  
 
The estimate of velocity for this isoform is 1.35 
µm.s-1 much faster than for α (0.45) or β (0.2). 
But this is dependent upon the assignment of 
kD* to 700 s-1.  If instead this is kD then there 
would be a missing value of kD* which could be 
much lower than 700 s-1 and result in a much 
lower velocity.  
 
Fast skeletal isoforms 
 
The adult fast skeletal isoforms,  IIa, IIb and IId, 
form a closely related group of myosins and in 
humans they have ~92 % sequence identity in 
the motor domain (18).  The ExOc is also 
believed to be a fast muscle isoform based on 
contractile velocity of extraocular and 
pharyngeal muscles (19, 20).  However, since it 
is only found in specialized muscle fibers 
expressing multiple isoforms, little is known 
about its biochemical and mechanical 
properties.  It is ~85 % identical to the adult fast 
isoforms. The experimental data for these four 
isoforms were published in two papers.  
Resnicow et al (21) published the first ever data 
on a set of recombinant  human isoforms and 
Bloemink et al (7) followed this with a more 
detailed biochemical kinetic study of the same 
isoforms.  The data in Table S1 is a summary of 
these studies. 
 
Notably, like many larger mammals, humans 
have not been found to express any IIb protein 
although the gene is intact and theoretically 
capable of expressing protein.  The IIb we 
characterized is thus the only human IIb to have 
been studied.  The fact that its properties appear 
similar to IIa and IId suggests that the gene has 
not degenerated significantly, despite not being 
expressed. 
 
The kcat values for the four isoforms (26 - 43 s-
1) are similar to that of Peri (29.9 s-1) and much 
faster than the cardiac and Emb isoforms.  As 
might have been expected, these four fast 
isoforms show a very similar pattern of 
occupancy of the states in the cycle (Fig 2 & 
S2) with IIb being slightly different relative to 
the other three isoforms.  The IIb isoform has a 
higher occupancy of the MT state and 
correspondingly lower A-M·D·Pi weakly 
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attached state at high actin concentrations. All 
four have low occupancy of the A·M·D state 
(<10% in each case) but with significant 
variation amongst the 4, varying from 2.5% to 
5.6% at [actin] = 3 Kapp. As seen for the Peri 
isoform the DR is not dominated by the A·M·D 
state; the other strongly attached states (A·M-
D, A·M-T) contribute equally to the DR. We set 
the fast isomerization steps controlling ADP 
release and actin dissociation arbitrarily as a 
fast event at 1000 s-1. It is possible that, for 
these very fast myosins, this value of 1000 s-1 is 
too slow and should be considerably faster.  We 
increased these values to 2000 or 3000 s-1 
individually or as a group and repeated the 
modeling. This made little difference to the 
overall balance of the cycle (see Table S5 for 
the data set for myosin IId and IIb) with only 
those intermediates closely associated to the 
modified rate constant changed, if at all.  For all 
other intermediates, the change was very small 
and always <10% of the initial value. The 
strongly attached states remained significantly 
occupied.   The presence of these additional 
strongly attached states has implications for the 
DR and how sensitive the cycle is to load.  This 
will be considered further below.   
 
Before considering the implications of the 
modeling for understanding the different 
mechanochemical cycles and the role for which 
each isoforms has been optimized, we should 
first consider the limitations of the data sets 
used. There are limited amounts of the protein 
available for the assays used to define the 
ATPase cycle, and for good experimental 
reasons all data sets were not collected under 
identical conditions. The early experiments (all 
fast isoforms) were done at 20o C and 0.1 M 
KCl in order to make a better comparison with 
physiological conditions. Later, the conditions 
were changed to 25 mM KCl as this lower salt 
concentration was required to generate more 
reliable actin-activated ATPase data.  The data 
presented for β myosin  were collected at 20o C 
at both 100 and 25 mM KCl (6, 22) and allowed 
us to make corrections between salt conditions 
for each measured parameter. Similar studies 
have been published for the rabbit IIa isoform 
at both salt concentrations and the corrections 
required were similar (6, 9).  Similarly there is 
an extensive collection of temperature 
dependence data on the β-isoform, from 
different sources, and for rabbit fast muscle 
myosin (23–27).  The observation that the 
corrections are similar for both the fast IIa and 
the β-cardiac isoforms supports our assumption 
that the corrections will be similar for each of 
the closely related isoforms used here - 
however this remains an assumption.  The 
measured values are all listed in Table S1, and 
the corrected values are used in Table 2.  
 
We state in the Methods section that we tested 
the robustness of our fitting by varying key 
fitted parameters by ± 20% and these have been 
published for the cardiac isoforms (9).   The 
supplementary information (Table S4) shows 
representative data for the Emb isoform where 
one of KD*, kD*, KT*, kT*, k-D or kH were varied 
and all others refitted. Most parameters are 
change by very little; those that change by > 
10% are highlighted in the Table S4 and are 
only those values directly linked to the altered 
parameter.   
 
Having defined the ATPase & cross-bridge 
cycle for each of the 8 isoforms, we will now 
consider the implications of the different cycles 
for the contraction of muscle fibers containing 
each of these isoforms.  Specifically, we will 
explore the maximum shortening velocity, the 
load-dependence of the cycle and the economy 
of ATP utilization. 
 
Maximum velocity of shortening, load 
dependence and economy of ATP usage. 
 
The maximum velocity of shortening (Vo; zero 
load) of a muscle fiber expressing a single 
isoform can be estimated from the lifetime (τ) 
of the strongly attached force holding state 
(predominantly AMD) and the individual step 
size of the working stroke, d,  
 V0 = d/τ 
From our modeling τ can be calculated from τ 
= DR/ATPase rate at any actin concentration.  
Since DR and ATPase rates have very similar 
dependence on actin concentrations (both 
proportional to the fractional saturation of 
myosin with actin) τ and hence V0 are 
independent of actin concentration in this 
model.   This means that the ATPase rate and 
velocity are not directly related except at 
saturating actin concentrations. The calculation 
of the V0   is identical for a contracting muscle 
fiber and velocity of actin movement in a 
motility assay, often measured in the absence of 
load. The model is therefore consistent with the 
observation that V0 is independent of the degree 
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of activation of a muscle and only a very small 
number of myosin cross-bridges are required to 
achieve V0. For the purposes of the arguments 
set out below we have assumed the working 
stroke, d, to be 5 nm for each isoform. 
 
The equation above assumes that the velocity is 
limited by the lifetime of the strongly attached 
states which, in the model used here, is 
controlled by the rate of cross-bridge 
detachment after completing the working 
stroke.  This has been demonstrated to be true 
for the relatively slow β-type myosin where the 
ADP release rate constant (kD*) is easily 
measured.  The same is true for the slow Emb 
isoform.  For all other isoforms the ADP release 
rate constant has not been measured because 
either the rate constant is too fast for current 
methods or the relevant A·M·D complex 
cannot be easily formed by simply mixing ADP 
with A·M. The equilibrium KD* in Fig 1 lies too 
far towards the A·M-D complex and little 
(<5%) A·M·D is formed.  For fast rabbit muscle 
myosin the value of KD* was estimated as ~50 
(28).  Thus we have good estimates of ADP 
release from β-cardiac and Emb myosin. For α, 
Peri and all fast muscle isoforms we have to 
estimate the ADP release based upon reasoned 
argument.   If ADP release is too fast, then the 
lifetime and steady-state occupancy of the force 
holding state becomes too small and a muscle 
would be unable to hold much force. For 
example, a 1% occupancy of the force holding 
state would mean only 3 force holding cross-
bridges for a fully activated 300 myosin thick 
filament.  If the rate constant is too slow, the 
velocity becomes smaller than that observed 
experimentally. Here we have set that value for 
these fast fibers at the minimal possible, 
compatible with the expected velocities. 
 
As noted above, fast muscle myosins have a 
higher predicted occupancy of other strongly 
attached states (dark blue); not just the A·M·D 
state.   When kD was doubled it had little effect 
on the occupancy of states in the cycle or the 
overall ATPase rates but velocity was increased 
by 15-20% and there was a 10% decline in the 
DR because of a ~10% fall in the A·M-D state.  
The system does remain, however, a 
detachment limited model. 
 
Fig 3B plots the predicted V0 values for each 
isoform and indicates there is an approximately 
20 fold range of velocities from Emb (0.09 
µm.s-1) to IId (1.66 µm.s-1).  The order of 
predicted velocities and their values relative to 
Emb velocity is Emb [1], β [2], α [4], Peri [8], 
IIa and ExOc [12], IId and IIb [20].  Thus, our 
analysis of the cross-bridge cycle predicts Emb 
to be both the slowest of the isoforms and the 
one most capable of holding large steady state 
loads; i.e. longest lifetime of the A·M·D state 
and the highest occupancy of A·M·D in the 
steady state. In contrast, IId was the fastest 
isoform and has the lowest DR, and hence 
lowest force holding capacity.   
 
The assumption of a 3 fold reduction in the rate 
constants for Pi and ADP release (kPi and kD*) 
induced by a 5 pN load predicts that for each 
isoform the different cycle characteristics result 
in different sensitivities of velocity to load.  
This effect of the cycle characteristics would 
remain true even if the measured load 
sensitivity varied for each isoform. The slower 
isoforms α, β and Emb have the highest 
sensitivity, with V0 being reduced by 2.7-2.8 
fold. The velocity of ExOc, IIa and Peri are 
reduced 2.1 fold while the fastest isoforms IId 
and IIb show only a 1.6-1.7 fold reduction.  
This reflects the relative importance of the 
A·M-D and A·M-T strongly attached states.  In 
the current model we have assumed that the fast 
events (rapid ADP release (KD), ATP binding 
(KT), and the ATP induced dissociation of actin 
(KT* & KT**) are not directly affected by load. 
 
The difference in load sensitivity of the cycle is 
reflected in the calculation of the economy of 
the isoforms shown in Fig 5 which plot  ATP 
used per second when holding a force of 5 pN 
(Fig 5A) and when shortening at maximum 
velocity and saturating actin (zero load, Fig 
5B).  At a 5 pN load both β and Emb myosin 
have a similar economical usage of ATP (~0.35 
ATP/sec/pN) and are more economical than α 
(~3 fold higher ATP usage) or the fast isoforms 
which use 1.5 to 2 fold more ATP than α 
myosin for the same load.  In contrast, Emb is 
not as efficient in turning ATPase activity into 
movement as β myosin (0.2 ATPper nm of 
travel) but is similar to alpha myosin which is 
uses just less than 0.5 ATP per nm.  Thus Emb 
myosin appears to be designed for slow 
movement but economical force holding.  As 
previously reported, this myosin is also able to 
continue functioning at much lower ATP 
concentrations than other myosin isoforms 
because of tight affinity for ATP (KT) (8).  This 
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property is shared with Peri and to a lesser 
extent with ExOc. 
 
To fully understand the mechanical behavior of 
a muscle fiber, the force-velocity relationship is 
required as this can define the power output 
(Force x velocity) and the velocity at which the 
power output of the muscle is maximal.   This 
is often considered to be the mechanical 
parameter that defines the optimal operating 
conditions for a muscle.  An equivalent of the 
force-velocity curve at the single molecule 
level has recently been developed which shows 
how point mutations and small molecules  can 
alter the relationship (29). Extrapolation 
between single molecule and whole fiber force-
velocity curves is not trivial due to interactions 
between motors in the ensemble and the 
elasticity of the sarcomere filament. Thus our 
data cannot be used at present to predict the 
force-velocity relationship.  However, the 
sarcomeric version of the MUSICO program is 
in principle capable of generating the force-
velocity relationship (9).  Modeling using this 
approach is a longer term project. 
 
Our predictions can be compared, to a limited 
extent, to the published data on human muscle 
fibers where the myosin isoforms present are 
well defined.  He et al (15) studied the force-
velocity and ATPase properties of slow and 
type IIa human muscle fibers containing only β-
myosin and myosin IIa respectively. Data were 
collected at 12 and 20 °C, and they calculated 
the economy of ATPase usage and the optimum 
velocities for power output.  Pellegrino et al 
(14) additionally reported the velocities of 
human Type I, IIa and IId/x fibers at 12 °C (and 
velocities for the same set of fibers from mice, 
rat and rabbit).  These studies therefore provide 
detailed muscle fiber data which can be 
compared to the predictions from our study. 
That said there are assumptions built in to any 
extrapolation from solution biochemistry to a 
muscle fiber that limits direct comparison.  
These include the number of myosin heads 
present and fully activated, in a muscle fiber, 
which in turn depends upon the density and 
packing of filaments in the muscle fiber.  The 
units used to report velocities and ATPases 
differ due to these corrections.   We will 
therefore limit ourselves to the values of the 
parameters relative to the values reported for 
Type 1 fibers containing β-myosin.  
 
Table 5 lists the relative values of V0, ATPase 
and ATP economy under isometric conditions, 
provided by Pellegrino et al and He et al (14, 
15).    The relative values of V0 at 12 °C for 
Type IIa fibers relative to Type I were 4.2 for 
Pellegrino et al (14) and 2.4 for He et al.  He et 
al had a similar ratio at 20 °C of 2.06 (15). Our 
data give a ratio nearer to that of Pellegrino of 
5.8 for type IIa and 8.65 for type IId, compared 
to Pellegrino’s value of 9.15.  Given the degree 
of error in each of these experimental 
measurements the values are of the correct 
order of magnitude. Similarly He et al 
measured the economy of ATP usage by Type 
I fibers to be 3.5 fold better than that of type IIa 
fibers.  In contrast we calculate a 2.4 fold 




Our modeling has revealed distinct 
characteristics of the ATPase cycle or each the 
human isoforms studied.  Differences lie in the 
overall speed of the ATPase cycle (kcat) and the 
balance of the events in the cycle which effects 
how much time the myosin spends at each point 
of the cycle.  There are three significant events 
in the cycle which define the characteristics of 
the cycle:  1) The Pi release step (kPi) which 
controls entry into the strong actin-binding, 
force holding states.  This event is shown as a 
single step but probably involves a myosin 
conformational change before or after the Pi 
release itself (30, 31).  2) The ADP release step 
controlled by the isomerization (kD*) which is 
followed by rapid ADP release, rapid ATP 
binding, and then actin dissociation.  Thus, the 
ADP coupled isomerization is linked to 
detachment of the cross-bridge.  3) Finally, the 
ATP hydrolysis step which limits how long the 
cross-bridge remains detached before again 
being available to bind actin as A-M·D·Pi, 
which then gives access to the Pi release and 
force generating step.  All other events are far 
more rapid and steps such as nucleotide 
binding/release and actin binding and release 
can be treated as rapid equilibration steps.   
Each of the myosins has a unique relationship 
between kcat and the three events which is 
simply illustrated in Table 4 by showing the 
value of kcat for each isoform and the value of 
each of the other rate constants relative to kcat.  
The values listed gives some an indication of 
the contribution of each transition to kcat.  In all 
cases at least one of the three values is ~ 2 times 
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kcat, highlighted with a grey background in 
Table 4.  This is kPi in most cases but for β and 
Peri the value of kH is smaller or comparable to 
kPi.  A second value for each myosin is ~3-5 
times kcat (yellow background). This is kH for 
all fast isoforms and α, while it is kD* for Emb 
and kPi for β and Peri.   The third value is ~ 10 
times kcat and this is kD* in most cases except 
Emb.   The value for α stands out as this is ~5 
times kcat and similar to the value of kH.  These 
different relationships between the three 
constants define the mechanical properties of 
the isoforms. 
 
The isometric force of muscle fibers is normally 
found to be relatively invariant within the limits 
of the precision of the measurement and 
proportional to the number of strongly attached 
cross-bridges – although a contribution of 
weakly attached bridges cannot be ruled out.   If 
this is true, then P0 will be a function of the 
number of active bridges and the DR.  If all 
bridges are active (a function of Ca2+ activation, 
force activation, the super relaxed states and 
phosphorylation effects none of which operates 
in our pure S1 and actin system), then P0 is a 
function of DR.  In our hands, the DR is a 
function of the actin concentration and the 
estimate of P0 will depend on the effective actin 
concentration present in the fiber.  For a truly 
isometric fiber the actin concentration may not 
be the same for every myosin head due to the 
mismatch of the actin and myosin filament 
helices in a muscle.  For this reason, we 
presented out data at different actin 
concentrations. 
 
Our data show that the DR varies between 
isoforms: 0.05-0.075 for fast isoforms and 0.1-
0.15 for slow/cardiac (even higher for Emb). 
Thus the expected P0 values per myosin head 
will be proportional to these DR values.  Of 
course in the fiber the myosins act as an 
ensemble and the mechanical coupling between 
myosin may alter these numbers. In addition, 
while the density of thick filaments in a muscle 
fiber may be similar for all fast muscles, 
variations in packing are expected in slow and 
developing muscle where cell contents are not 
so exclusively packed with myofilaments. 
 
The predicted V0 values vary in a way roughly 
compatible with expectation, the velocities are 
expected to be independent of actin 
concentration and so should be independent of 
the packing of filaments in the fiber.  However, 
a question remains if unloaded shortening truly 
exists in the muscle fiber where some internal 
load may always be present, and therefore 
measured values will underestimate the true V0.  
Comparison of V0 muscle fiber values with 
motility velocities rarely show exact 
correspondence for reasons not yet fully 
explained.  Although myosin orientation on the 
surface and the exact make up of actin filaments 
are thought to play a part in such discrepancies 
(32).  
 
A limitation of our analysis is the limited data 
available on the load dependence of myosin 
isoforms. In the absence of experimental data 
we have made the simplifying assumption that 
the load dependence is the same in each case. 
While this assumption may not be true our 
modeling does illustrate how differences in the 
cycle alone can generate different load 
sensitivities for the isoforms.  Force-velocity 
curves for muscle fibers in principle contains 
the information on load dependence but are not 
available for many fibers containing a single 
myosin isoforms. 
 
The solution data do not currently allow us to 
generate a force-velocity curve which would be 
required to define the optimal velocity for 
power output for each myosin type.  This is 
believed to be the condition where the muscle 
is designed to operate.  Vo and Po will provide 
the end points for the Force-Velocity curve but 
the shape of the relationship is distinct for 
different fibers and may depend on internal 
muscle elastic elements in addition to the 
ATPase cycle of different myosin motor 
domains. Single molecule methods or loaded 
motility assays could be used to measure the 
load dependence of individual myosin 
isoforms.  This will reveal if the myosin motor 
domain itself defines the shape of force velocity 
curve. 
 
In common with most studies of myosin in 
solution our data uses 20 °C and 25 mM KCl as 
the reference conditions.   These are some way 
from the physiological conditions of 0.15-0.17 
M ionic strength and 37 C.  The as stated above 
the conditions are needed to allow accurate 
measurement of the ATPase and motility data 
and to allow comparison with muscle fiber 
mechanics.  Extrapolation to physiological 
conditions is possible for the well define β-
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cardiac myosin and adult fast muscle myosin 
where there is extensive data on the temperature 
and salt dependence of many of the parameters.  




Our analysis of the differences in the cross-
bridge cycle for each myosin isoform raises the 
issue of the sequence changes that bring about 
the adaptations to function.   Earlier studies 
have examined groups of isoforms to identify 
key sequence changes (18, 33–35). These have 
often emphasised the variable surface loops in 
which isoform specific sequence changes 
occur.  However, the source of the sequence 
changes required to bring about the changes in 
the overall balance of the cross-bridge cycle are 
likely to be more widespread. We show a 
sequence alignment of the 8 human isoforms in 
Fig S5 and outline the major areas where 
changes occur in the legend to the figure. These 
include an area (residues 302-339) which 
corresponds to one of the alternate spliced 
regions in the Drosophila muscle myosins. 
Actin binding Loop-3 (residues 561-579) and 
Loop-4 (residues near 370) and helix-O 
(residues 425-451) in the upper 50kDa domain. 
These areas are of interest since the same areas 
were highlighted in a study of the sequence 
variation of the β-cardiac myosin motor domain 
associated with changes in velocity between 
mammals (36). Future analyses will include a 
combination of bioinformatics, modeling and 
experimental investigation to define the 
sequences that generate the different properties 
of sarcomeric myosins and are responsible for 





Protein expression and purification: 
 
Human muscle MyHC-sS1 for the β isoform 
and MyHC-S1 for the α-isoform were 
expressed and purified as described previously 
(6).  The motor domain of the β heavy chain 
was co-expressed with the N-terminal His6-
tagged, human essential light-chain MYL3.  
The motor domain of the Emb myosin isoform 
was expressed with a His6-tag on the C-
terminus (8).   The fast muscle isoforms (IIb, 
IId, IIa), Peri, and ExOc isoforms were 
expressed with a C-terminally fused enhanced 
GFP and His6-tag.  All proteins carrying a C-
terminal His6-tag when purified carried the 
endogenous mouse light chains present in the 
C2C12 cells (see Table 1 (21). Briefly, 
replication incompetent recombinant 
adenoviruses were produced using the pAdEasy 
system containing expression cassettes 
encoding S1 of the human myosins under the 
transcriptional control of a CMV promoter. The 
adenoviral particles were amplified using 
HEK293 cells; the viruses were purified using 
CsCl gradients, and the concentrated virus was 
stored in a glycerol buffer at -20 °C. These 
adenoviruses were used to infect C2C12 
myotubes in culture and cells were collected 
and frozen into cell pellets.  Pellets were then 
homogenized in a low salt buffer and 
centrifuged, and the supernatants were purified 
by affinity chromatography using a HisTrap HP 
1 ml column. The proteins were then dialyzed 
into the low salt experimental buffer (25 mM 
KCl, 20 mM MOPS, 5 mM MgCl2, 1mM DTT, 
pH 7.0). 
 
Actin was prepared from rabbit muscle as 
previously described (37). The actin was 
labelled with pyrene at Cys-374 as previously 
described (38). When used at sub-micromolar 
concentrations the actin was stabilized by 




Fast kinetic data for every isoform except for 
the Peri isoform have been previously 
published (6–8). All kinetic measurements for 
the Peri isoform were performed as previously 
described (6–8).  Solutions were buffered with 
20 mM MOPS, 5 mM MgCl2, 25 mM KCl, 1 
mM DTT at pH 7.0, and measurements were 
conducted at 20 °C on a High-Tech Scientific 
SF-61 DX2 stopped-flow system. Traces were 
analyzed in Kinetic Studio (TgK Scientific) and 
Origin (OriginLab).  The experimental data for 
all isoforms is summarized in Table S1. 
ATPase data for Peri, ExOc, IIa, IIb and IId 
isoforms were performed at 37 °C (21). To 
calculate the expected kcat values at 20 °C, a Q10 




The published set of rate and equilibrium 
constants are summarized in Table S1, together 
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with the kcat and Kapp values from steady-state 
actin-activated ATPase assays.  With this data, 
the 8-state actin.myosin ATPase cycle was 
modelled using the MUSICO software 
(available at 
https://www.mijailovichlab.org/download) as 
described by (9, 10).  The 8-step scheme of Fig 
1 has a total of 24 rate and equilibrium 
constants but not all are independent.  For each 
step, i, Ki = ki/k-i and thus only two of the 
constants need to be defined experimentally for 
a complete description of the cycle. The free 
energy of ATP hydrolysis further constrains the 
overall balance of the cycle.  Experiments have 
defined forward rate constants kD*, kT*, kH, and 
the equilibrium constants KT and either KD or 
KDKD*, in most cases to a precision of at least 
20% (see Supplementary Table 1). The rate 
constants k-T* and kD are defined as diffusion 
limited. The events kT** and k-A are considered 
too fast to measure, and so have little effect on 
the modeling. Fitting the model to the actin-
dependent steady-state ATPase data can give 
estimates for the equilibrium constants for actin 
binding (KA), ATP hydrolysis (KH) and on-
actin hydrolysis step (KAH,) and the rate 
constants for phosphate release and ATP 
dissociation (kPi and kT respectively). The Ki = 
ki/k-i detailed balance equation can be used to 
define KT*, kA, k-pi, k-D*, k-D and k-T, k-H and k-
AH. Initial concentration of ATP was set at 5 
mM, and ADP and Pi at 0 mM; under steady-
state conditions these are assumed to be zero.  
 
The fraction of myosin in the strongly attached 
states AMD, AM-D, AM and AMT in the 
steady state, is defined as the DR.  From DR, an 
estimate of the maximal velocity, Vo, can be 
calculated from the equation Vo=d/τ, where d is 
the distance over which myosin can produce 
force, and τ is the lifetime of the strongly 
attached state. The lifetime of the attached state 
is equal to DR/ATPase rate, hence, Vo = 
d·ATPase/DR. The economy, or the amount of 
ATP used per myosin per nm of travel when the 
ATPase and the velocity are maximal can be 
derived from EconomyV (ATP/nm) = Vmax 
(ATP/sec) / Vo (nm/sec). 
In our previous modeling we used the data from 
two laboratories that used single molecule laser 
trap methods to define the effect of load on the 
ADP release step of the cycle ( kD*; (12, 13)) .  
These indicted that for β-cardiac a 5 pN load on 
actin.myosin slowed the ADP release by ~3 
fold.   A similar effect on the power stroke 
(coupled to Pi release in our 8 state model) is 
also required to slow the ATPase cycling by ~3-
fold as reported for muscle fibers under 
isometric conditions (15).   Here, in the absence 
of any direct measurements on any other 
isoform, we make the assumption that all 
isoforms have a similar load dependence.   
While this is an over simplification it does 
allows us to illustrate how load affects each 
isoform differently due to the changed balance 
of events in the cycle.  To estimate the economy 
of ATP usage per pN of force generated at any 
actin concentration, the ATPase rate was 
divided by the load, here 5 pN. 
 
Error analysis: 
The sensitivity matrices shown in Fig S3 
demonstrate that with the exception of k-T, the 
fitted parameters are all well defined in the 
modeling program; values in the diagonal of 
>0.8 indicate well resolved parameters with 
little codependence. As reported previously (9), 
varying one of the fitted parameters (kH, k-D, 
KD*, k-D*, k-T* or KT*) by ± 20 % has minimal 
effect on the best fit values for the remaining 
parameters. This observation remained true for 
the data presented in this study (see Table S4 
for analysis of the emb data), with the 
remaining parameters varying by much less 
than 20%, with a few exceptions.  
In our previous paper on DCM mutations in β-
cardiac myosin we also explored the effect of a 
20 % error in the value of Vmax (kcat) or Kapp used 
in the fitting.   These again showed the data is 
reasonably robust.  Kapp is primarily defined by 
the value of KA and a 20% change in Kapp has 
little effect on the cycle apart from a change in 
KA.  This is also because we model the data at 
different actin concentration related to KA.  
Changes in Vmax will change the flux round the 
cycle.  Vmax is largely controlled by a 
combination of kPi and kH depending upon the 
isoform and these will adjust as the kH changes 
by 20%.   If kAMD does not change and we use 
our measured value then the occupancy of 
AMD must change to increase or decrease the 
flux through this sate to match the altered Vmax. 
Thus AMD will change by some fraction of 
20% but no more than this. A 20% change is 
within the tolerance we claim for the overall 
precision of the cycle and will not alter 
substantially the pattern seen for each isoform. 
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Table 1. Summary of Isoforms 





in muscle fiber* 
Light chains** Expression 
tags on heavy 
chain 
















Embryonic (Emb) MYH3 





Perinatal (Peri) MYH8 






Extraocular (Exoc) MYH13 
Extraocular and laryngeal 
muscles 
 
None e-GFP, 6xHis 
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Table 2. Fitted Rate and Equilibrium Constants of the ATPase cycle. Highlighted to show which are fitted, which are measured and which derived from 
assumption or detailed balance. Buffer conditions are as follows: 25 mM KCl, 20 mM MOPS, 5 mM MgCl2 and 1 mM NaN3. 
A. Equilibrium Constants 
 Units α-S1 β-S1 Emb Peri ExOc IIa  IIb IId 
Kapp μM 67.8 39.55 39 20.6 18.6 22.5 7 7.9 
kcat s
-1 18 5.94 7 29.9 29.6 26.4 43.1 32.9 
KA μM
-1 0.011 0.0107 0.0164 0.0241 0.035 0.0293 0.0874 0.0913 
Kpi mM 100 100 100 100 100 100 100 100 
KD*   50 0.167 0.2 50 50 50 50 50 
KD μM 197 36 71.43 100 100 100 100 100 
KT μM
-1 0.004 0.003 0.0119 0.0068 0.00834 0.0045 0.0042 0.005 
KT*   150 154 77.7 85.6 138 135 146 122.8 
KT** μM 1000 1000 1000 1000 1000 1000 1000 1000 
KH   4.1 8.9 6.3 16.6 35.7 23.2 29.2 31.3 
KAH   52.76 63.145 43.6 34 55 47.5 30 32.5 
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B. Forward Rate Constants 
 Units α-S1 β-S1 Emb Peri ExOc IIa IIb IId 
kA μM
-1s-1 10.68 10.75 16.4 24.1 3.51 2.93 8.47 9.13 
kPi s
-1 32.14 15.95 13.1 69.2 50.1 44.5 86 52.3 
kD* s
-1 100 59 22 700 400 400 1000 1000 
kD s
-1 1970 1000 1000 1000 1000 1000 1000 1000 
kT μM
-1s-1 27.6 10.05 10.13 10.67 10.27 10.37 10.1 10.9 
kT* s
-1 1800 1543 777 856 1380 1350 1460 1228 
kT** s
-1 1000 1000 1000 1000 1000 1000 1000 1000 
kH s
-1 77.2 12.5 82.4 66.6 107.2 92.8 116.7 125.2 
kAH s
-1 79.1 12.6 87.2 68 110 95 120 130 
 
NB. kD* values in red were measured with an ADP-displacement with excess ATP assay. For the other isoforms which have a low affinity of ADP for 
actin·S1, the ADP release rate will be faster than the maximal rate of ATP induced actin·S1 dissociation and therefore too fast to be measured by ADP 
displacement.  
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C. Backward Rate Constants 
 
Units α-S1 β-S1 Emb Peri ExOc IIa IIb IId 
 
k-A 
s-1 1000 1000 1000 1000 1000 1000 1000 1000 
k-Pi mM
-1s-1 0.321 0.159 0.13 0.692 0.501 0.445 0.86 0.523 
k-D* s
-1 2 354 110 14 8 8 20 20 
k-D  μM
-1s-1 10 27.8 14 10 10 10 10 10 
k-T s
-1 6597 3349 851.5 1569.2 1230.9 2304.4 2396.6 2179.3 
k-T* s
-1 12 10 10 10 10 10 10 10 
k-T** μM
-1s-1 1 1 1 1 1 1 1 1 
k-H s
-1 19 1.4 13 4 3 4 4 4 
k-AH s
-1 1.5 0.2 2 2 2 2 4 4 
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Detached Weakly attached Strongly attached Duty Ratio Velocity 
(μm s-1) 
Alpha 
 Kapp = 67.8 
9.00 0.60 0.30 0.10 0.10 0.45 
 3 Kapp = 203.4 
13.50 0.38 0.47 0.15 0.15 0.45 
 20 Kapp = 1356 
17.14 0.14 0.67 0.19 0.19 0.45 
 3 Kapp + Load 
5.27 0.33 0.51 0.16 0.16 0.16 
Beta  
      
 Kapp = 39.55 
2.97 0.73 0.20 0.073 0.073 0.20 
 3 Kapp = 75 
4.46 0.57 0.32 0.11 0.11 0.20 
 20 Kapp = 500 
5.66 0.30 0.56 0.14 0.14 0.20 
 3 Kapp + Load 
1.97 0.47 0.39 0.14 0.14 0.071 
Embryonic 
 Kapp = 39 
3.51 0.54 0.28 0.19 0.19 0.095 
 3 Kapp = 117 
5.27 0.30 0.42 0.28 0.28 0.095 
 20 Kapp = 780 
6.68 0.093 0.55 0.35 0.35 0.095 
 3 Kapp + Load 
1.89 0.29 0.44 0.27 0.27 0.035 
Perinatal 
 Kapp = 20.6 14.92 0.71 0.23 0.055 0.055 1.36 
 3 Kapp = 61.8 22.41 0.55 0.36 0.083 0.083 1.35 
 20 Kapp = 412 28.44 0.34 0.55 0.11 0.11 1.34 
 3 Kapp + Load 10.19 0.47 0.46 0.067 0.067 0.76 
Extraocular 
 Kapp = 18.6 
14.82 0.62 0.312 0.064 0.064 1.17 
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 3 Kapp = 55.8 
22.24 0.43 0.47 0.095 0.095 1.17 
 20 Kapp = 372 
28.16 0.23 0.65 0.12 0.12 1.16 
 3 Kapp + Load 
8.94 0.37 0.55 0.083 0.083 0.54 
IIa 
 Kapp = 22.5 
13.21 0.63 0.31 0.057 0.057 1.16 
 3 Kapp = 67.5 
19.82 0.44 0.48 0.086 0.086 1.16 
 20 Kapp = 450 
25.11 0.23 0.66 0.11 0.11 1.15 
 3 Kapp + Load 
7.98 0.37 0.55 0.074 0.074 0.54 
IIb 
 Kapp = 7 
21.59 0.67 0.27 0.060 0.060 1.81 
 3 Kapp = 21 
32.47 0.5 0.41 0.090 0.090 1.81 
 20 Kapp = 140 
41.0 0.34 0.55 0.11 0.11 1.80 
 3 Kapp + Load 
14.12 0.42 0.51 0.067 0.067 1.049 
IId 
 Kapp = 8 
16.47 0.62 0.33 0.048 0.048 1.73 
 3 Kapp = 24 
24.77 0.42 0.50 0.072 0.072 1.73 
 20 Kapp = 160 
31.27 0.25 0.66 0.091 0.091 1.72 
 3 Kapp + Load 
9.93 0.37 0.58 0.049 0.049 1.02 
  




Table 4. Balance of significant rate constants around the ATPase cycle 
Isoform kcat kPi/kcat kD*/kcat kH/kcat 
α 18.00 1.78 5.56 4.28 
β 6.00 2.67 9.83 2.07 
Emb 7.00 1.87 3.14 11.71 
Peri 29.90 2.31 23.4 2.23 
Exoc 29.60 1.69 13.51 3.72 
IIa 26.40 1.74 15.15 3.60 
IIb 43.10 2.09 23.20 2.78 
IId 32.40 1.64 30.86 4.01 
 
N.B. The slowest step (grey background) are in each case ~ 2x the kcat value.  If this step is largely irreversible (true for kPi not always true for kH)  then ~ 50 % 
of the myosin will occupy the state before this slow step (kcat = θ.k;  where θ is the fractional occupancy of that state and k is the rate constant for the breakdown 
of that state. 
The second slowest step in all cases (yellow background) are ~3-4 times kcat and since θ = kcat/k then θ ~ 0.25. 
The third slowest step in each case is ~10 times kcat and so the occupancy of the relevant state will be approximately 0.1. 
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Table 5. Comparison to Human muscle fiber data.   
Fiber/myosin 
type 
V0 12 °C 
(µm/s/hs) ‡  




V0 20 °C * 
Muscle Lengths/sec  
 
Isometric 









economy 20 °C 





0.37±0.06 (1.0) 1.15±0.36 (1.0) 1 0.2 (1.0) 0.7 (1.0) 
IIa 1.40±0.10 
(4.2) 
0.88±0.12 (2.4) 2.37±0.34 (2.06) 3.5 1.16 (5.8) 1.7 (2.4) 
IId 3.02±0.935 
(9.15) 
   1.73 (8.65)  
 
Values in parenthesis are relative to the Type I fiber/β myosin isoform.  ‡ from ref  (14);  * from ref  (15) 





Figure 1. ATP driven actomyosin cross-bridge cycle. The black circles represent an actin filament 
composed of 3 actin monomers. Myosin is shown as 2 ellipses and a rod; the larger ellipse represents 
the upper and lower 50 k domains, the smaller ellipse and rod representing the converter domain, lever 
arm and light-chain binding region. Myosin in a strongly attached, force-holding state is represented in 
blue, weakly attached in yellow and detached in red shades. Green characters are the equilibrium 
constants for each step defined in the direction of ATP hydrolysis (clockwise).  





Figure 2. Fractional occupancies of each state in the ATPase at 3 different actin concentrations, 
[A] = Kapp, 3Kapp, and 20 Kapp for each isoform and at [A] = 3Kapp plus 5 pN load.  Colours of the Pie 
chart bans match those of Figure 1. The % value next to each chart gives the % of each cycle spent as 
the force holding A·M·D state.  
  





Figure 3.  Plots of the estimated ATPase and V0 values at [actin] = 3 Kapp and the effect of a 5 pN load.  
The numbers give the loaded value as a fraction of the unloaded value.




Figure 4. The estimated value of the Duty Ratio and the occupancy of the main force holding state 
A·M·D at [actin] = 3 Kapp and the effect of a 5 pN load.  The numbers with each isoform give the 5 pN 
loaded value as a fraction of the unloaded value.  




Figure 5. The economy of ATP usage (per myosin head). A) when holding a 5 pN load.  EconomyL = 
ATPase (ATP/sec)/ 5 (pN) (where ATPase is estimated at [actin] = 3Kapp, assuming a similar load 
dependence for each isoform); B) when shortening at maximum velocity (V0) and Vmax for the ATPase 
Economyv (ATP/nm) = Vmax (ATP/sec) / Vo ( nm/sec). 
 
 
